Hi all, can't wait for ePAT to get listed, looks like there's huge potential.
However just want to discuss about the "pre-verbal children" target market they're developing for soon.
As a parent, if my 1yr old is sick or in "pain" I would just use the recommended dose of panadol or nerofen, regardless of the "pain scale" the toddler is experiencing.
I can understanding for aged old people to vary the painkillers depending on the pain. But for toddlers and babies, parents don't want to risk long term damage giving them 2 shots of painkillers, they'll just go to the doctors if it gets worse.
So would parents still need the ePAT app to tell them this? Is this a big market to develop for.. .after taking on the dementia market?
Also another thing I'm worried about is the "Use of Funds – 2 year budget" on their end of August presentation.
If the funds are to last them without any CR for 2 yrs, their sales and marketing seems at bit low especially if they're going to target 2 markets. Their corp & admin is more than their R&D and S&M combined.
Any civil discussion on this would be greatly appreciated, thank you.
Capital Raising Fees $340,000 9%
Research & Development $973,000 24%
Sales & Marketing $511,000 13%
Intellectual Property & Regulatory $225,000 6%
Corporate & Administration $1,671,000 42%
Working Capital $280,000 7%
